Argus Research raises Albemarle PT on earnings recovery forecast

Argus Research raises price target for lithium producer Albemarle ALB.N to $140 from $120; representing a premium of ~17% on the stock's last close

Brokerage says trends in the lithium market are impacting ALB's current earnings, which have turned negative, but the company's balance sheet is solid, and management is taking steps to reduce costs and conserve cash

"Our 12-month target price of $140 assumes an earnings recovery into 2026"- brokerage

Eight out of 27 brokerages rate the stock "buy" or higher, 16 "hold" and three "sell" or lower; their median PT is $100 - data compiled by LSEG

Shares of ALB up ~5% at $120.49 premarket over 2026 demand growth forecast

Up to last close, stock up ~34% YTD